| abstract |
Use of a biocompatible polymer, which responds to the general formula (I) below A represents glucose, X represents an RCOOR 'cluster, AaXxYy (I) Y represents an O or N-sulfonate cluster fixed on A and responds to one of the following formulas -ROSO3R ', -RNSO3R', in which: R represents an aliphatic, possibly branched and / or unsaturated hydrocarbon chain and which may contain one or more aromatic cycles and R 'represents a hydrogen atom or a cation, a represents the number of monomers, it is already such that the mass of said polymers of formula (I) is greater than about 2,000 Daltons, x represents the degree of substitution of monomers A by groupings X, and x is between about 20 and 150% and represents the degree of substitution of monomers A with clusters Y, and and is between approximately 30 and 150%, for the preparation of a pharmaceutical, dermatological or cosmetic composition ca o of a medicinal device intended for prevention, pain relief. |